Avacta Group (LON:AVCT) Shares Up 12.7% - Here's What Happened

Avacta Group Plc (LON:AVCT - Get Free Report)'s share price rose 12.7% on Tuesday . The company traded as high as GBX 31 ($0.42) and last traded at GBX 31 ($0.42). Approximately 3,044,731 shares changed hands during trading, an increase of 80% from the average daily volume of 1,689,436 shares. The stock had previously closed at GBX 27.50 ($0.37).

Avacta Group Trading Up 1.3%

The stock has a market cap of £144.37 million, a PE ratio of -4.89 and a beta of 1.12. The company has a debt-to-equity ratio of 52.53, a current ratio of 1.29 and a quick ratio of 4.96. The stock has a 50-day moving average price of GBX 34.51 and a two-hundred day moving average price of GBX 41.80.

About Avacta Group

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics. The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US. Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).